Skip to main content

Dapagliflozin’s T2D renal protection extends to ‘fast decline’ of eGFR

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Dapagliflozin’s T2D renal protection extends to ‘fast decline’ of eGFR

User login

Username

Password

Reset your password

Type	Lead	score